Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
NEUROCRINE BIOSCIENCES INC (NBIX)
Gano Kyle — Director
Shares
1,812
Price
$132.71
Total Value
$240.48K
Shares Held After
140,407
% of Holdings
1.3%
NEUROCRINE BIOSCIENCES INC (NBIX)
Gano Kyle — Director
Shares
34,588
Price
$132.70
Total Value
$4.59M
Shares Held After
140,407
% of Holdings
19.8%
GLAUKOS Corp (GKOS)
Burns Thomas William — Director
Shares
186,945
Price
$115.00
Total Value
$21.50M
Shares Held After
153,775
% of Holdings
54.9%
Sharps Technology, Inc. (STSS)
Saba Capital Management, L.P. — 10% Owner
Shares
12,182
Price
$2.37
Total Value
$28.87K
Shares Held After
1,511,988
% of Holdings
0.8%
Phreesia, Inc. (PHR)
VanDuyn Amy Beth — SVP, Human Resources
Shares
2,202
Price
$16.36
Total Value
$36.02K
Shares Held After
157,349
% of Holdings
1.4%
Phreesia, Inc. (PHR)
Roberts Evan — President, Provider Solutions
Shares
6,268
Price
$16.36
Total Value
$102.52K
Shares Held After
826,554
% of Holdings
0.8%
Phreesia, Inc. (PHR)
Linetsky David — President, Network Solutions
Shares
6,038
Price
$16.36
Total Value
$98.76K
Shares Held After
223,942
% of Holdings
2.6%
Phreesia, Inc. (PHR)
Indig Chaim — Director
Shares
9,595
Price
$16.36
Total Value
$156.94K
Shares Held After
1,361,535
% of Holdings
0.7%
Phreesia, Inc. (PHR)
Hoffman Allison C — General Counsel & Secretary
Shares
3,995
Price
$16.36
Total Value
$65.35K
Shares Held After
169,661
% of Holdings
2.3%
Phreesia, Inc. (PHR)
Gandhi Balaji — Chief Financial Officer
Shares
4,687
Price
$16.36
Total Value
$76.66K
Shares Held After
150,569
% of Holdings
3.0%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$39.52
Total Value
$790.35K
Shares Held After
40,000
% of Holdings
33.3%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$460.98
Total Value
$23.05K
Shares Held After
320
% of Holdings
13.5%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
100,000
Price
$1.04
Total Value
$103.77K
Shares Held After
466,991
% of Holdings
21.4%
BIODESIX INC (BDSX)
Vazquez Chris — Chief Accounting Officer
Shares
83
Price
$8.15
Total Value
$676.39
Shares Held After
1,072
% of Holdings
7.2%
BIODESIX INC (BDSX)
Pestano Gary Anthony — Chief Development Officer
Shares
298
Price
$8.15
Total Value
$2.43K
Shares Held After
8,446
% of Holdings
3.4%
BIODESIX INC (BDSX)
O'Kane Kieran — Chief Commercial Officer
Shares
298
Price
$8.15
Total Value
$2.43K
Shares Held After
7,869
% of Holdings
3.6%
BIODESIX INC (BDSX)
Hutton Scott — Director
Shares
970
Price
$8.15
Total Value
$7.90K
Shares Held After
38,974
% of Holdings
2.4%
BIODESIX INC (BDSX)
Cowie Robin Harper — CFO, Sec'y & Treasurer
Shares
298
Price
$8.15
Total Value
$2.43K
Shares Held After
13,654
% of Holdings
2.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
38,782
Price
$0.54
Total Value
$20.94K
Shares Held After
2,159,860
% of Holdings
1.8%
Exicure, Inc. (XCUR)
Exicure HiTron Inc. — 10% Owner
Shares
734,747
Price
$4.50
Total Value
$3.31M
Shares Held After
1,857,314
% of Holdings
28.3%
Akanda Corp. (AKAN)
HRT FINANCIAL LP — 10% Owner
Shares
7,868
Price
$1.29
Total Value
$10.15K
Shares Held After
7,816
% of Holdings
50.2%
Neogen Corporation (NEOG)
Nassif Mikheal — Director
Shares
137
Price
$9.33
Total Value
$1.28K
Shares Held After
632
% of Holdings
21.7%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$124.31
Total Value
$372.93K
Shares Held After
150,503
% of Holdings
2.0%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
7,521
Price
$37.53
Total Value
$282.23K
Shares Held After
288,976
% of Holdings
2.5%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
61,228
Price
$37.02
Total Value
$2.27M
Shares Held After
296,497
% of Holdings
17.1%
Phreesia, Inc. (PHR)
Hui Yvonne — Principal Accounting Officer
Shares
379
Price
$16.17
Total Value
$6.13K
Shares Held After
29,166
% of Holdings
1.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,619
Price
$32.24
Total Value
$84.43K
Shares Held After
1,518
% of Holdings
63.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,381
Price
$31.56
Total Value
$138.28K
Shares Held After
4,137
% of Holdings
51.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$90.99
Total Value
$181.98K
Shares Held After
0
% of Holdings
100.0%
BECTON DICKINSON & CO (BDX)
Garrison Michael David — EVP & Pres Med.Essntl&BioPharm
Shares
1,010
Price
$206.54
Total Value
$208.61K
Shares Held After
12,095
% of Holdings
7.7%
BECTON DICKINSON & CO (BDX)
Garrison Michael David — EVP & Pres Med.Essntl&BioPharm
Shares
600
Price
$209.00
Total Value
$125.40K
Shares Held After
13,105
% of Holdings
4.4%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
14,871
Price
$22.78
Total Value
$338.78K
Shares Held After
1,027,015
% of Holdings
1.4%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
15,129
Price
$22.19
Total Value
$335.67K
Shares Held After
1,041,886
% of Holdings
1.4%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$49.20
Total Value
$98.40K
Shares Held After
128,443
% of Holdings
1.5%
Immuneering Corp (IMRX)
Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Shares
2,298
Price
$4.57
Total Value
$10.50K
Shares Held After
376,496
% of Holdings
0.6%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Commercial Officer
Shares
3,000
Price
$124.31
Total Value
$372.93K
Shares Held After
103,221
% of Holdings
2.8%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
200
Price
$27.40
Total Value
$5.48K
Shares Held After
395,575
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
8,300
Price
$26.83
Total Value
$222.65K
Shares Held After
395,775
% of Holdings
2.1%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
2,909
Price
$1.58
Total Value
$4.59K
Shares Held After
1,197,462
% of Holdings
0.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
136,193
Price
$13.59
Total Value
$1.85M
Shares Held After
3,378,621
% of Holdings
3.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
136,193
Price
$13.58
Total Value
$1.85M
Shares Held After
3,378,546
% of Holdings
3.9%
Harmony Biosciences Holdings, Inc. (HRMY)
Kapadia Sandip — CHIEF FINANCIAL OFFICER
Shares
20,961
Price
$35.92
Total Value
$752.83K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Sharps Technology, Inc. (STSS)
Saba Capital Management, L.P. — 10% Owner
Shares
25,000
Price
$2.30
Total Value
$57.50K
Shares Held After
1,524,170
% of Holdings
1.6%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
26,046
Price
$2.07
Total Value
$53.92K
Shares Held After
390,023
% of Holdings
6.3%
Nkarta, Inc. (NKTX)
Mahmood Nadir — President
Shares
5,649
Price
$2.07
Total Value
$11.69K
Shares Held After
167,727
% of Holdings
3.3%
CareDx, Inc (CDNA)
Hanna John Walter JR — Director
Shares
10,156
Price
$21.05
Total Value
$213.80K
Shares Held After
616,885
% of Holdings
1.6%
Showing 501–550 of 1606 transactions (page 11 of 33)